Caregen Co., Ltd.

As of June 30, 2026, Caregen Co., Ltd. carries a market capitalization of 3.37T, placing it among publicly traded companies globally. Its enterprise value stands at 3.33T, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Caregen Co., Ltd.'s next confirmed earnings release is scheduled for November 6, 2026.

As of June 30, 2026, Caregen Co., Ltd. has 48.87M shares outstanding.

As of June 30, 2026, Caregen Co., Ltd. trades at a trailing price-to-earnings ratio of 147.25. The price-to-sales ratio is 44.97, and the price-to-book ratio stands at 15.40.

As of June 30, 2026, Caregen Co., Ltd. trades at an EV/EBITDA multiple of 142.61 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 44.48 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 182.66 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. Caregen Co., Ltd. trades at an EV/FCF ratio of 155.46, comparing the total takeover cost of the business to the cash it actually generates for all capital providers. These enterprise value multiples are built on an enterprise value of 3.33T versus a market cap of 3.37T, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, Caregen Co., Ltd. maintains a current ratio of 7.93, meaning it holds 7.9x the short-term assets needed to cover near-term liabilities.

Over the twelve months ended June 30, 2026, Caregen Co., Ltd. posted a return on equity (ROE) of 10.50, showing how much profit the company earns on every dollar of shareholder capital. Return on invested capital (ROIC) comes in at 7.36 - the clearest signal of whether the business earns more on its capital than that capital costs, and the core measure of a durable competitive advantage. Return on assets (ROA) stands at 9.63, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 10.50, useful for judging operating efficiency across full business cycles. The company generates approximately 376.36M in revenue per employee across its workforce of 199.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 1.02 indicates how many times Caregen Co., Ltd. sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2026, Caregen Co., Ltd. recorded 3.66B in income tax expense. That works out to an effective tax rate of 13.78, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 26.53B, leaving 22.87B in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on October 23, 2026, Caregen Co., Ltd.'s stock has declined approximately 42.83% over the past 52 weeks. The 50-day moving average sits at 46,298.00, while the 200-day moving average is 79,241.50.

Over the twelve months ended June 30, 2026, Caregen Co., Ltd. generated 74.90B in revenue and converted that into 22.87B in net income, yielding earnings per share of 467.92. EBITDA reached 23.36B, while operating income came in at 18.24B.

These figures are as of June 30, 2026. Total book value stands at 218.66B, with working capital of 80.68B providing operational flexibility.

Caregen Co., Ltd. produced 26.15B in operating cash flow over the twelve months ended June 30, 2026. After subtracting -4.71B in capital expenditures, free cash flow totaled 21.43B - equivalent to 438.42 per share.

Over the twelve months ended June 30, 2026, Caregen Co., Ltd. posted a gross margin of 71.03, reflecting its pricing power and cost economics. The operating margin of 24.35 and net profit margin of 30.54 provide insight into operational efficiency.

Over the twelve months ended June 30, 2026, Caregen Co., Ltd. paid dividends of 236.95 per share. The dividend payout ratio of 50.64 indicates the proportion of earnings distributed to shareholders, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Free cash flow yield stands at 0.64, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt.

Caregen Co., Ltd.'s most recent stock split took place on August 25, 2023 with a 1:5 split ratio.

As of June 30, 2026, Caregen Co., Ltd. has an Altman Z-Score of 92.02, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.